May 10 |
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2024 Earnings Call Transcript
|
May 10 |
Lineage Cell Therapeutics Q1 2024 Earnings: Aligns with EPS Projections Amidst Revenue Declines
|
May 10 |
Q1 2024 Lineage Cell Therapeutics Inc Earnings Call
|
May 6 |
OpRegenĀ® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
|
May 2 |
Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024
|
Apr 30 |
Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)
|
Apr 29 |
Lineage Cell Therapeutics board chairman passes away
|
Apr 29 |
Lineage Announces Changes to Board of Directors
|
Apr 19 |
12 Cheap Foods With Anti-Aging Properties That Longevity Scientists Swear By
|
Apr 1 |
Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development
|